E11 | Five States. Five Races. Zero Safe Seats for Big Pharma.

Last week, Ken Paxton won the Republican Senate primary runoff in Texas. He beat John Cornyn — six-term incumbent, former Senate majority whip, the establishment's choice — because Texas Republican primary voters chose the candidate who had sued Big Pharma. Multiple times. Using words like "illegal" and "bribe."The week before that, Bill Cassidy lost in Louisiana. In Episode 11, Rob Burgess connects those two results to four other Senate races unfolding right now — and shows you exactly what to do with the information.Texas. Ohio. Georgia. Colorado. New Jersey. In every one of these races, pharmaceutical accountability has emerged as a defining issue. Rob examines each one honestly — the legislative records, the contribution histories, the rhetorical commitments versus the documented actions — and closes with three specific questions every voter should be asking their Senate candidates before November.In this episode:Ken Paxton's actual record against Big Pharma: the Eli Lilly lawsuit, the February kickback lawsuit, Johnson & Johnson, Bristol-Myers Squibb — lawsuits, not press releasesThe Texas Democratic nominee ran on pharmaceutical accountability too. Both candidates in the Texas Senate race are running against Big Pharma.Ohio: Sherrod Brown's legislative record on drug pricing, his $1.4 million in pharmaceutical contributions, and the question this show asks regardless of partyGeorgia: Jon Ossoff passed two laws. The Inflation Reduction Act delivered 38-79% price reductions on ten drugs. That's not a campaign ad — it's a result.New Jersey: Cory Booker, pharmaceutical industry concentration, and what returning donations actually meansColorado: The accountability argument is now penetrating Democratic primaries — the same dynamic that ended Cassidy's career in a Republican primary91% of Republican voters, 70% of independents, 64% of Democrats support MFN codification. The primaries are starting to reflect it.Three questions to ask every Senate candidate before you vote — with specific answers that separate a record from a talking pointThe bottom line: The pharmaceutical industry cannot lobby every voter. It can lobby every senator. Your job is to create senators the lobby cannot own.🔔 New episodes every week — subscribe so you don't miss one. 🌐 Get involved at BustBigPharma.com#DrugPricing #HealthcareReform #BigPharmaExposed #PharmaGreed #CorruptionWatch